Predict SpA (MIL:PRE) Asset Impairment Charge : €0.00 Mil (TTM As of Jun. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Predict SpA Asset Impairment Charge?

Predict SpA's Asset Impairment Charge for the six months ended in Jun. 2024 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Predict SpA Asset Impairment Charge Historical Data

The historical data trend for Predict SpA's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Predict SpA Asset Impairment Charge Chart

Predict SpA Annual Data

Trend

Dec22

Dec23

Dec24

Asset Impairment Charge

Predict SpA Semi-Annual Data
	Dec22	Dec23	Jun24	Dec24
Asset Impairment Charge	-	-	-	-

Predict SpA Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

Predict SpA Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Predict SpA's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Predict SpA Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Predict SpA (MIL:PRE) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

N/A

Address

c/o Fiera del Levante Pad. 105, Viale Adriatico, Bari, ITA, 70132

Website

https://www.predictcare.it

Predict SpA develops innovative healthcare technologies, such as Optip and Mistral, and sells medical diagnostic imaging systems. Its products include Versana Active GE, Optic probe, Versana Balance GE, Voluson S-series, and Vivid T8.